Alverbratt, Charlotte, et al. “Radium-223 Use and Survival by Line of Treatment in Metastatic Castration-Resistant Prostate Cancer: A Nationwide Population-Based Register Study”. Acta Oncologica, vol. 64, Oct. 2025, pp. 1391-03, doi:10.2340/1651-226X.2025.43794.